Opus Genetics, Inc. (IRD) Dividend History

Opus Genetics, Inc. is a biotechnology company focused on pioneering gene therapies and innovative treatments for genetic disorders. The company leverages advanced genomic technologies to develop targeted solutions aimed at improving patient outcomes and addressing unmet medical needs in the genetic medicine space.

Dividend History

Opus Genetics, Inc. currently does not pay dividends

Company News

Opus Genetics Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients with Visual Disturbances Under Mesopic, Low-Contrast Conditions

Opus Genetics announced positive results from its LYNX-2 Phase 3 trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating vision disturbances in keratorefractive patients. The study met its primary endpoint, showing a significant improvement in mesopic low contrast distance visual acuity compared to placebo.

GlobeNewswire Inc.

Featured Companies: VTRS
Top 10 Small-Cap Stocks to Watch in 2025

The article discusses 10 small-cap stocks that could outperform in 2025, citing factors like falling interest rates, low valuations, and potential shifts in industrial production.

Investing.com

Featured Companies: AUNA CNTX CRGO EVGO FFIC IKT OKLO PENG WOLF

Dividend data last updated 06/07/2025 21:58:27 UTC